• Home
  • Store
    • Newsletter Subscriptions
    • Multimedia
    • Books
    • eBooks
    • ABPN SA Courses
    • Social Work Courses
  • CME Center
  • Multimedia
    • Podcast
    • Webinars
    • Blog
    • Psychiatry News Videos
    • Medication Guide Videos
  • Newsletters
    • General Psychiatry
    • Child Psychiatry
    • Addiction Treatment
    • Hospital Psychiatry
    • Geriatric Psychiatry
    • Psychotherapy and Social Work
  • FAQs
  • Med Fact Book Apps
  • Log In
  • Register
  • Welcome
  • Sign Out
  • Subscribe
Home » Blogs » The Carlat Psychiatry Blog » Looking Ahead To 2019 Newsletter Topics

The Carlat Psychiatry Blog
The Carlat Psychiatry Blog RSS FeedRSS

Looking Ahead To 2019 Newsletter Topics

January 10, 2019
Subscribers can look forward to some great content throughout the year for all three newsletters. Here's what the editors-in-chief have to say about the useful articles they are working on to help you improve patient outcomes.

The Carlat Psychiatry Report

There’s no shortage of information on prescribing medications, but when and how do we stop them? The first issue of 2019 tackles the interesting topic of deprescribing, along with research updates on cannabidiol for schizophrenia and the potential downsides to ketamine.

The next issue will cover dark and light therapy (or chronotherapy),  followed by issues on preventative treatments, sleep disorders, depression, handling insurance, side effects, antipsychotics, complementary alternative medicines, and improving psychiatrist/patient relationships.



Needless to say we've got a lot of great material coming up with solid input from experts in these fields. Hope it's helpful!

Chris Aiken, MD
Editor-in-Chief of The Carlat Psychiatry Report
Subscribe Here

 

 

The Carlat Child Psychiatry Report

For our first issue of 2019 on anxiety, we spoke with Dr. Moira Rynn at Duke about the concept of anxiety as a pervasive symptom that cuts across diagnostic categories. We are focused on anxiety as a target symptom that happens every day, but what are the data for medication treatment? We have an update on what works.



Our next issue will be on trauma, followed by issues covering mood disorders, psychosis, substance use, and autism.

Joshua Feder, MD
Editor-in-Chief of The Carlat Child Psychiatry Report
Subscribe Here

 

 

The Carlat Addiction Treatment Report

First of all, we’d like to wish our readers a happy and prosperous New Year!

And as ever, thank you for your feedback and suggestions. In 2019, we aim to continue to provide you with unbiased, practical, and readable content, while keeping our tone compassionate and patient-centered. We’ll start the year off with an issue on board verification in addiction medicine—a new board open to physicians from most specialties. Other topics we aim to cover this year include the intersection of addiction and traumatic brain injury, co-occurring psychiatric disorders, infectious diseases, forensic issues, and suicide.

Bachaar Arnaout, MD

This list is not exhaustive, of course, as we are always on the lookout for relevant and timely information. Please continue to write to us!

Bachaar Arnaout, MD
Editor-in-Chief of The Carlat Addiction Treatment Report
Subscribe Here
Carlat Total Access Subscriptions: Get access to every article on the website.

Complete access to every article you search on the website.

Shop for Total Access
Free Psychiatry Updates
The latest unbiased psychiatric information sent to your inbox.
Specify Your Interests
Featured Book
  • HospPsychiatry_Spiral_Binding_Sm.png

    Hospital Psychiatry Fact Book, First Edition (2025) - Spiral Bound

    This comprehensive guide is designed to be a valuable resource for professionals working in...
    READ MORE
Featured Video
  • KarXT (Cobenfy)_ The Breakthrough Antipsychotic That Could Change Everything.jpg
    General Psychiatry

    KarXT (Cobenfy): The Breakthrough Antipsychotic That Could Change Everything

    Read More
Featured Podcast
  • shutterstock_2637648401.jpg
    General Psychiatry

    Psychopharm Secrets: Coming Off Meds

    There’s a hidden placebo response to watch for when patients stop meds on their own.
    Listen now
Recommended
  • Join Our Writing Team

    July 18, 2024
    WriteForUs.png
  • Insights About a Rare Transmissible Form of Alzheimer's Disease

    February 9, 2024
    shutterstock_2417738561_PeopleImages.com_Yuri A.png
  • How to Fulfill the DEA's One Time, 8-Hour Training Requirement for Registered Practitioners

    May 24, 2024
    DEA_Checkbox.png
  • Join Our Writing Team

    July 18, 2024
    WriteForUs.png
  • Insights About a Rare Transmissible Form of Alzheimer's Disease

    February 9, 2024
    shutterstock_2417738561_PeopleImages.com_Yuri A.png
  • How to Fulfill the DEA's One Time, 8-Hour Training Requirement for Registered Practitioners

    May 24, 2024
    DEA_Checkbox.png
  • Join Our Writing Team

    July 18, 2024
    WriteForUs.png
  • Insights About a Rare Transmissible Form of Alzheimer's Disease

    February 9, 2024
    shutterstock_2417738561_PeopleImages.com_Yuri A.png
  • How to Fulfill the DEA's One Time, 8-Hour Training Requirement for Registered Practitioners

    May 24, 2024
    DEA_Checkbox.png

About

  • About Us
  • CME Center
  • FAQ
  • Contact Us

Shop Online

  • Newsletters
  • Multimedia Subscriptions
  • Books
  • eBooks
  • ABPN Self-Assessment Courses

Newsletters

  • The Carlat Psychiatry Report
  • The Carlat Child Psychiatry Report
  • The Carlat Addiction Treatment Report
  • The Carlat Hospital Psychiatry Report
  • The Carlat Geriatric Psychiatry Report
  • The Carlat Psychotherapy Report

Contact

carlat@thecarlatreport.com

866-348-9279

PO Box 626, Newburyport MA 01950

Follow Us

Please see our Terms and Conditions, Privacy Policy, Subscription Agreement, Use of Cookies, and Hardware/Software Requirements to view our website.

© 2025 Carlat Publishing, LLC and Affiliates, All Rights Reserved.